Paid ads company for healthcare specialists · 400M+ revenue generated · fully online, working globally
Home / Case studies / Weight-loss clinics
A practical guide to paid ads for medical weight-loss and obesity clinics in the UK, Australia and the USA: which platforms fit, which rules apply, and a simple 90-day plan.
By Ammar. .
The short version
Weight loss is one of the most closely watched areas of health advertising. Regulators have acted against ads for prescription injectables and against ads that play on body image. Clinics that win trust lead with medical care, safety and long-term support, not a named drug or a quick result.
What patients often search for
In the UK and Australia, prescription-only weight-loss medicines cannot be advertised to the public. That includes naming them and promoting them indirectly.
Promote your programme and your clinicians, such as medical review, nutrition and follow-up, not a named medicine.
Never play on body image or shame. The ASA, Meta, Snapchat and Reddit all act on this.
In the USA, never suggest compounded products are the same as, or approved like, brand-name medicines.
The patient journey
Every step is a chance to earn trust or lose it. This is the path I plan around.
Weight care led by real clinicians.
Clear fees. Quick replies. Private and secure.
Book a consultationNext appointments
Mon 9:00Tue 11:30Thu 2:00Illustration only. Not a real client page.
Blueprint
Start small, get the basics right, then grow. The order matters.
Decide what your programme is, for example medical review, nutrition, activity and follow-up. Decide who does what, and what is prescribed only after a clinical assessment.
Check registration, prescribing and pharmacy rules for each place you operate. Check which medicines are prescription-only and what you may say about them in ads.
Use Google Ads for programme and local searches, with certification where required. Meta and Snapchat weight-loss ads must target adults 18+. Snapchat also bans weight-loss supplements, and LinkedIn and Reddit set their own limits on claims and images.
Write calm, supportive ads about your programme and clinicians, never about a named medicine or a body. Send people to landing pages with fees, safety information and a clear guide to the first consultation.
Track consultation bookings by campaign, and keep health details out of ad tools.
Email patients who agreed with supportive follow-up. Keep medicine names out of promotions where the rules do not allow them, and review the ad results each month.
Three markets
The patient journey looks similar everywhere. The rules, funding and search habits do not.
Patients search for support with their weight, often after trying other approaches. Some come through the NHS, and many look for private clinics, pharmacies and online providers.
Prescription-only medicines cannot be advertised to the public under the CAP Code. In December 2025 the ASA ruled against weight-loss ads that named these medicines or promoted them indirectly, for example through a landing page that named them. Social media posts that promote a company’s services can count as ads. The ASA also acted against ads that played on body image. CAP had issued an enforcement notice on 23 September 2025.
Programme-led ads with clear clinician and registration details, and social posts checked against the ASA rules.
Patients search for weight management support, and many ask their GP. Online and telehealth services are common.
The TGA says it is unlawful to advertise prescription-only weight-loss medicines to the public. One online health company was issued 10 infringement notices totalling $198,000 for alleged unlawful advertising. Semaglutide and tirzepatide are prescription-only in Australia. The TGA also says compounded products are not identical to approved products, and says changes to the regulations mean pharmacists can no longer compound GLP-1 products. Testimonials are also not allowed in advertising a regulated health service.
Programme ads that do not name prescription medicines, no testimonials, careful use of images, and ads for referring GPs.
Patients search for medical weight loss, often through telehealth, and they compare price, speed and what is prescribed.
In March 2026 the FDA sent 30 warning letters to telehealth companies over compounded GLP-1 marketing. The letters cited claims that implied FDA approval, used brand names such as Wegovy to describe compounded products, or made unsupported claims. Google requires certification for telehealth, and separate certification to advertise GLP-1 and other prescription weight-loss terms. On Meta, weight-loss ads must target adults aged 18 and over, and negative statements about physical appearance are not allowed.
A clear split between compounded and approved medicines, platform certifications applied for early, and claims you can support.
General information, not legal advice. Rules change, and these points were checked on 23 October 2026. Always confirm with your regulator, professional body or lawyer before you advertise.
How I help
One specialist to plan the ads, run them and report on them, so you can focus on patients.
Work I have done
Open invitation
I am building real case studies for this industry and I do not invent results. If you run a weight-loss clinic, we can agree a clear plan and honest reporting. With your permission, we can later write up what worked and share it here.
First 90 days
This is a plan, not a promise. Timing depends on approvals, content and your team, and I never guarantee results.
Questions
Not to the public in the UK or Australia. They are prescription-only, and both countries ban advertising them to the public, including indirect promotion. You can promote your programme and consultation and describe the medical assessment, but not the named medicine. In the USA the rules differ, and the FDA and the ad platforms are strict, especially for compounded products.
Be careful. The ASA has ruled that an ad can break the rules if it links to a landing page that names prescription-only medicines. Keep named medicines out of ads and promotional pages, and ask a regulatory adviser about any information pages.
It is risky. The FDA’s 2026 warning-letter guidance advises removing before-and-after images and unsupported claims, and Meta does not allow negative statements about physical appearance. Snapchat and Reddit also do not allow before-and-after images in weight-loss ads. In Australia, testimonials are not allowed. I recommend leading with your clinicians, your process and honest information.
Google and Meta allow them with conditions, and Meta requires adults 18+. Snapchat requires 18+, bans weight-loss supplements, and does not allow before-and-after images or body shaming. Reddit does not allow before-and-after images or body shaming, and LinkedIn bans unrealistic weight-loss claims. I check each platform’s current rules before a campaign goes live.
Sources and notes
These links were checked on 23 October 2026. Some points, such as referral routes and funding, come from general knowledge of how each system works, so confirm them with the official body.
Healthcare paid ads specialist in Adelaide, working fully online with healthcare practices in the UK, Australia and the USA. About me
Next step
Tell me about your practice and where you want to grow. I will reply with honest next steps.
Start a conversation→Next steps
See how I run Facebook and Instagram ads for this specialty, then try the calculator.
Let’s talk
Tell us about your practice and your country. We reply fast, and the first call is free.
Get a free proposal→